Skip to main content
logo
GT Biopharma logo
GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
6.68
+0.72 (12.08%)
At close: Oct 9, 2026, 4:00 PM EDT
6.80
+0.12 (1.80%)
After-hours: Oct 9, 2026, 7:56 PM EDT

GT Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1287112993
Market Cap Growth
217.19%22.55%-35.48%-63.37%-69.01%159.69%
Enterprise Value
760-5857
Last Close Price
6.6819.6376.25191.25664.282287.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.351.44-4.081.412.464.25
P/TBV Ratio
3.381.44-1.412.464.25

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.010.020.00
Net Debt / Equity Ratio
-1.39-1.182.37-1.86-1.39-1.46
Net Debt / FCF Ratio
0.340.530.311.571.072.05
Quick Ratio
2.242.940.672.113.343.12
Current Ratio
2.613.500.722.123.353.14
Return on Equity (ROE)
-113.52%-1377.41%-453.39%-79.09%-124.15%-
Return on Assets (ROA)
-158.16%-125.85%-97.89%-55.02%-54.33%-190.04%
Return on Capital Employed (ROCE)
-457.70%-214.70%860.10%-181.60%-180.20%-262.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-94.41%-339.51%-193.14%-71.93%-72.42%-62.35%
FCF Yield
-119.69%-154.63%-189.36%-83.81%-52.77%-16.77%
Buyback Yield / Dilution
-795.21%-190.57%-40.78%-26.87%-13.19%-
SEC Filings: 10-K · 10-Q